| Accession Number: | 0001437749-23-025204 |
| Date: | 2023-08-31 |
| Issuer: | UROGEN PHARMA LTD. (URGN) |
| Original Submission Date: |
SMITH JASON DREW
400 ALEXANDER PARK DRIVE
PRINCETON, NJ 08540
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| ORDINARY SHARES | 2023-08-31 | M | 8,334 | a | $0.00 | 22,207 | direct | ||
| ORDINARY SHARES | 2023-08-31 | S | 3,800 | d | $18.01 | 18,407 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RESTRICTED STOCK UNITS | 0.0 | 2023-08-31 | deemed execution date | M | 8,334 (d) | ordinary shares 8,334 | $0.00 | 0 | direct |
| ID | footnote |
|---|---|
| f1 | each restricted stock unit ("rsu") represents a contingent right to receive one ordinary share of the issuer. |
| f2 | represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| f3 | the reporting person was granted rsus on august 31, 2020 representing 25,000 ordinary shares. the rsus vested in three equal installments on november 30, 2021, august 31, 2022 and august 31, 2023. |
